Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc. financial statements

Tempest Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 26.26M10-K
Cash and equivalentsUSD 7.71M10-Q
Total debtUSD 010-K

Tempest Therapeutics, Inc. financials on 6ix · Tempest Therapeutics, Inc. on 6ix